Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centersCARY, N.C. and…
LegacyCoin CTO Announces Launch of Crypto Ownership Solution Focused on Digital Asset Continuity
DUBAI, United Arab Emirates, March 28, 2026 (GLOBE NEWSWIRE) -- LegacyCoin CTO…
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…
ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye…
Beko Announces CEO Transition; Strategic Continuity and Sustainability to Remain Core Priorities
ISTANBUL, Feb. 13, 2026 /PRNewswire/ -- Beko (Arçelik A.Ş.) (Bloomberg: ARCLK TI)…
National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations
The Medidata Data Experience offering will enable the National Cancer Institute Lead…
Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors
BRADENTON, Fla., Aug. 6, 2025 /PRNewswire/ -- Continuity Biosciences, a company pioneering…
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global…
Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
BRADENTON, Fla., June 4, 2025 /PRNewswire/ -- Continuity Biosciences, LLC, a developer…
